drugset / Trial / NCT03472495
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to compare the incidence of rate control (defined as: HR \<110 beats/min or conversion to sinus rhythm) at 2 hours after medication administration between oral immediate release diltiazem and intravenous continuous infusion diltiazem.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2021-03-21
- Completion
- 2021-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diltiazem | Small molecule | 2.5 mg | Oral |
| Comparator | Diltiazem | Small molecule | 5 mg | Oral |
| Comparator | Diltiazem | Small molecule | 15 mg | Oral |
| Comparator | Diltiazem | Small molecule | 30 mg | Oral |
| Comparator | Diltiazem | Small molecule | 60 mg | Oral |